Featuring Matthew Feeney, Policy Analyst, Cato Institute; Marc Scribner, Research Fellow, Competitive Enterprise Institute; and Dean Baker, Co-Director, Center for Economic and Policy Research; moderated by Brink Lindsey, Vice President for Research, Cato Institute.
Obesity remains a serious health problem and it is no secret that many people want to lose weight. Behavioral economists typically argue that “nudges” help individuals with various decisionmaking flaws to live longer, healthier, and better lives. In an article in the new issue of Regulation, Michael L. Marlow discusses how nudging by government differs from nudging by markets, and explains why market nudging is the more promising avenue for helping citizens to lose weight.
Two long wars, chronic deficits, the financial crisis, the costly drug war, the growth of executive power under Presidents Bush and Obama, and the revelations about NSA abuses, have given rise to a growing libertarian movement in our country – with a greater focus on individual liberty and less government power. David Boaz’s newly released The Libertarian Mind is a comprehensive guide to the history, philosophy, and growth of the libertarian movement, with incisive analyses of today’s most pressing issues and policies.
Featuring Hon. Bob Barr, Liberty Strategies; Pat Nolan, Vice President, Prison Fellowship; Cheye Calvo, Mayor, Berwyn Heights, Maryland;
and Tim Lynch, Director of the Cato Institute’s Project on Criminal Justice.
President Obama’s new drug czar, Gil Kerlikowske, says he wants to banish the idea of a “war on drugs” because the federal government should not be “at war with the people of this country.” An important and welcome announcement, to be sure, but what government policies will be actually adjusted, canceled, or reversed? At a minimum, the time is right to reverse the militarization of law enforcement, abolish mandatory minimum sentencing, and stop federal meddling in the state referendum and initiative process. Join us for a wide-ranging discussion regarding new directions for federal drug policy.